ArticleFrontiers in oncology2022

A novel cervix carcinoma biomarker: Pathological-epigenomics, integrated analysis of MethylMix algorithm and pathology for predicting response to cancer immunotherapy.

Yu-Chong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.